Clinical experience, device handling, and pre-market data highlighted at the SNF-ALICE meeting

At the SNF-ALICE meeting, Ton-Bridge shared focused academic insights into intracranial aneurysm treatment technologies, with discussions covering both fully radiopaque DFT braided devices and Blue-Shield coated embolization assist stent technology.

SNF-ALICE meeting

One session focused on the operational precautions and clinical experience of a fully radiopaque DFT Kylin Flow Diverter. The discussion highlighted key considerations in device handling, visibility, deployment control, and clinical use in complex aneurysm treatment.

intracranial aneurysm treatment technologies

Another session presented the design characteristics and pre-market clinical data of the Blue-Shield coated embolization assist stent. As represented by the FALCOEmbolization Assist Stent, the technology is designed to support clear visualization, controlled deployment, and reliable assistance during coil embolization procedures.

fully radiopaque DFT

Together with the Kylin Flow Diverter, Ton-Bridge continues to advance its neurovascular innovation platform through device design, surface technology, and clinical evidence generation.

Optimized  braiding design

More highlights from the SNF-ALICE meeting and live cases are available on the official English channel:https://lnkd.in/eidjbf4S

 


Post time: Jul-24-2026